Related Experiment Video
Updated: Mar 24, 2026

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
Provider Perspective on Integrative Medicine for Pediatric Sickle Cell Disease-related Pain
Caitlin M Neri1, Tishra Beeson2, Holly Mead3
1Division of Pediatric Hematology, Boston Medical Center, Massachusetts; Department of Pediatrics, Boston University School of Medicine (Dr Neri), United States.
Insights
Provider perspectives on integrative medicine (IM) for pediatric sickle cell disease (SCD) pain are positive but underutilized. Barriers include lack of integration processes and inconsistent funding, highlighting a need for improved protocols and provider education.
Area of Science:
- Integrative Medicine
- Pediatric Hematology
- Pain Management
Background:
- Integrative medicine (IM) is explored for managing pain in pediatric sickle cell disease (SCD).
- Understanding healthcare provider perspectives is crucial for effective implementation of IM in SCD care.
Purpose of the Study:
- To explore provider views on using IM for pain in children with SCD.
- To develop recommendations for enhancing IM promotion in pediatric SCD management.
Main Methods:
- Qualitative case study design.
- Criterion-type purposeful sampling of hematology providers.
- Semistructured interviews analyzed using NVivo software.
Main Results:
- Ten provider interviews revealed generally positive attitudes towards IM for SCD pain.
- Providers identified a lack of integration processes and transient funding as key barriers.
- Variable provider comfort levels and a desire for increased knowledge regarding IM were noted.
Conclusions:
- Developing clear protocols for IM integration into SCD management plans is recommended.
- Educating providers on IM's utility, efficacy, and available resources can promote its use for pediatric SCD pain.
Objective:
Integrative medicine (IM) approaches are sometimes used to manage sickle cell disease (SCD)-related pain. The purpose of this research is to (1) understand provider perspective towards the use of IM for pain in children with SCD at a large urban children's hospital and (2) provide recommendations on how to better promote IM for children and adolescents with SCD.
Methods:
After approval from the institutional review board, a qualitative case study approach was used with criterion-type purposeful sampling to select providers from the division of hematology to adequately inform the study. Semistructured interviews were completed using audiotape to facilitate transcription. NVivo 10 analytic software (QSR International Pty Ltd, Doncaster, Victoria, Australia) was used to organize data into themes to answer the study questions.
Results:
Ten provider interviews were completed. Attitudes were generally positive, and most providers felt that IM is generally helpful. All providers reported that they do not optimally use integrative therapies for children with SCD. The barriers uncovered focused on lack of process for integration of IM, specifically that IM resources seem transient and based on short-term funding. Provider attitude towards CAM is generally positive, but provider comfort level is highly variable. No providers are completely comfortable with their knowledge base about IM, and increased knowledge is desired.
Conclusions:
Creation of protocols and processes to incorporate IM into management plans for patients with SCD could help to promote its use. Education of providers about utility and efficacy of IM for SCD-related pain and about existing resources would aid in promotion of IM for children with SCD.
More Related Videos
05:23Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
08:23Characterization of Sickling During Controlled Automated Deoxygenation with Oxygen Gradient Ektacytometry
Published on: November 5, 2019
Related Concept Videos
Analgesia and Pain Management
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Pharmacokinetics in Pediatric Patients: Drug Distribution